| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 07/05/2001 | WO2001047918A2 Azolyalkyl-oxa(di)azolyl pyri(mi)dine derivatives, a method for their production and their use as pesticides |
| 07/05/2001 | WO2001047905A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047886A1 Nitrile derivatives as cathepsin k inhibitors |
| 07/05/2001 | WO2001047880A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047879A1 Pyrrolidines which inhibit camp-specific pde |
| 07/05/2001 | WO2001000231A3 Use of cpg as an adjuvant for malaria vaccine |
| 07/05/2001 | WO2000078332A3 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 07/05/2001 | WO2000070046A3 Secreted polypeptides and corresponding polynucleotides |
| 07/05/2001 | WO2000061621A3 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 07/05/2001 | WO2000035945A8 Cyclic peptide antifungal agents having a sugar substituent |
| 07/05/2001 | WO2000034483A9 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 07/05/2001 | US20010007031 Enantiomers of 8-aminoquinoline; antiparasitic compounds for treatment or prevention of Pneumocystis carinii pneumonia, toxoplasmosis, malaria, leishmaniasis, or trypsonosomia |
| 07/05/2001 | US20010006962 Behavior of biologically active compounds favorably modified by replacing a functional group with an unsaturated fatty derivative, e.g. elaidic acid; bioavailability; membrane passage; organ targeting; drugs; agriculture |
| 07/05/2001 | US20010006640 Compounds and methods to inhibit or augment an inflammatory response |
| 07/05/2001 | DE19962901A1 Azolylalkalylazol-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel Azolylalkalylazol-derivatives, processes for their preparation and their use as pesticides |
| 07/05/2001 | CA2395543A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | CA2395179A1 Nitrile derivatives as cathepsin k inhibitors |
| 07/05/2001 | CA2395173A1 Pyrrolidines which inhibit camp-specific pde |
| 07/04/2001 | EP1113008A1 4-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivatives useful as antibacterial and antiprotozoal agents |
| 07/04/2001 | EP1112746A2 Eimeria strains as Coccidiosis vaccines |
| 07/04/2001 | EP1112251A1 Azetidine derivatives, preparation and medicines containing them |
| 07/04/2001 | EP0789586B1 Compounds for the prevention and treatment of helminth infections |
| 07/04/2001 | EP0634927B1 Treatment and prophylaxis of diseases caused by parasites, or bacteria |
| 07/04/2001 | CN1302296A Novel 2-alkyl substituted imidazole compounds |
| 07/04/2001 | CN1302293A Benzazole compounds and their use |
| 07/04/2001 | CN1302184A Composition for keeping away vermin |
| 07/04/2001 | CN1067890C Drug for curing infection disease of fowl |
| 07/03/2001 | US6255348 Use of aminoadamantane compounds as immunoregulators |
| 07/03/2001 | US6255333 Humans or animals |
| 07/03/2001 | US6255316 Crystal structure |
| 07/03/2001 | US6255100 Cyclosporin fermentation process |
| 07/03/2001 | US6254869 Genetic engineering, vaccines and immunoglobulins |
| 07/03/2001 | CA2009508C Pf 1022 substance, method of producing same and anthelmintic composition containing same |
| 06/30/2001 | CA2293852A1 Procedure for preparing active plant extracts used to trap free radicals; the extracts and compounds and devices containing them |
| 06/29/2001 | CA2328781A1 Novel antibacterial and prokinetic macrolides |
| 06/29/2001 | CA2328775A1 4-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivatives |
| 06/28/2001 | WO2001046443A2 Proteases |
| 06/28/2001 | WO2001046258A2 Transporters and ion channels |
| 06/28/2001 | WO2001046255A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046184A1 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | WO2001046136A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | WO2001046127A1 Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| 06/28/2001 | WO2001046126A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 06/28/2001 | WO2001045735A2 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen |
| 06/28/2001 | WO2001037667A8 Combination of n-phenyl-n'-benzoyl urea derivative and nectin compounds for parasite control |
| 06/28/2001 | US20010005725 Antiparasitic compounds such as 4-(2,2-dibromocyclopropyl)-1-(2,6-dichloro-4-trifluoromethylphenyl)-1,2,3 -triazole |
| 06/28/2001 | DE19960204A1 Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Norlbornylamino substituted derivatives, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing |
| 06/28/2001 | CA2395202A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | CA2395197A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 06/28/2001 | CA2395007A1 Transporters and ion channels |
| 06/28/2001 | CA2394789A1 Proteases |
| 06/28/2001 | CA2392787A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/27/2001 | EP1109818A1 Phosphoepoxides, method for making same and uses |
| 06/27/2001 | EP1109817A1 Phosphohalohydrins, method for making same and uses |
| 06/27/2001 | EP1109812A2 Pyrrolobenzodiazepines |
| 06/27/2001 | EP1109811A2 Pyrrolobenzodiazepines |
| 06/27/2001 | EP1109794A1 Aza-cyclodepsipeptides and their use as antiparasitics |
| 06/27/2001 | EP1109574A1 Vaccine against sexually transmitted diseases |
| 06/27/2001 | EP0831896B1 In ovo vaccination against coccidiosis |
| 06/26/2001 | US6251914 Treating cytokine mediated diseases |
| 06/21/2001 | WO2001044474A1 2871 receptor, a g-protein coupled receptor and methods of use thereof |
| 06/21/2001 | WO2001044245A1 Saccharin derivatives as orally active elastase inhibitors |
| 06/21/2001 | WO2001044238A1 Pyrazolyl benzyl ethers |
| 06/21/2001 | WO2001044190A1 Anthracene derivatives as anti-cancer agents |
| 06/21/2001 | WO2001044164A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds |
| 06/21/2001 | WO2001043775A2 Hydroxide-releasing agents as skin permeation enhancers |
| 06/21/2001 | WO2001043768A2 Vaccine composition comprising the toxoplasma protein sag3 |
| 06/21/2001 | CA2395486A1 Saccharin derivatives as orally active elastase inhibitors |
| 06/21/2001 | CA2395170A1 Anti-cancer agents (iii) |
| 06/21/2001 | CA2394130A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds |
| 06/21/2001 | CA2393762A1 Hydroxide-releasing agents as skin permeation enhancers |
| 06/20/2001 | EP1108738A2 Immunostimulating carrier for vaccines |
| 06/20/2001 | EP1108017A2 G-motif oligonucleotides and uses thereof |
| 06/20/2001 | EP1107981A2 Ring modified cyclic peptide analogs |
| 06/20/2001 | EP1107969A2 Collections of compounds |
| 06/20/2001 | EP1107962A1 Quinolin-2-one derivatives useful as anticancer agents |
| 06/20/2001 | EP1107779A2 Medicaments for manipulating t-cell immune response |
| 06/20/2001 | EP1107776A1 Dry extract of henna, method for producing said extract and use of the same |
| 06/20/2001 | EP1107772A2 Probiotic, lactic acid-producing bacteria and uses thereof |
| 06/20/2001 | EP1107767A2 Use of selenium for treating patients suffering from systemic inflammatory response syndrome (sirs), and composition for implementing said treatment |
| 06/20/2001 | EP1107741A1 Orally administered controlled drug delivery system providing temporal and spatial control |
| 06/20/2001 | CN1299647A Delayed praziquantel bar for dog |
| 06/20/2001 | CN1067392C Stable crystalline tetrahydrofolic acid salts |
| 06/19/2001 | US6248872 Nucleotide sequences which code enzymatic protein; for use in detection and treatment of dirofilaria infection |
| 06/19/2001 | US6248787 Reducing cachexia |
| 06/19/2001 | US6248363 Improved delivery of hydrophilic or hydrophobic pharmaceutical active ingredients, such as drugs, nutraceuticals, cosmeceuticals and diagnostic agents |
| 06/19/2001 | US6248331 Treponema pallidum fused antigen and assay for anti-treponema pallidum antibodies using the same fused antigen |
| 06/19/2001 | US6248329 Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| 06/14/2001 | WO2001042449A2 Methods for introducing genes into mammalian subjects |
| 06/14/2001 | WO2001042301A1 Interferon-alpha induced gene |
| 06/14/2001 | WO2001042288A2 G-protein coupled receptors |
| 06/14/2001 | WO2001042241A1 Substituted pyridazines having cytokine inhibitory activity |
| 06/14/2001 | WO2001041785A2 Enzyme treatment for infection |
| 06/14/2001 | WO2001028537A3 Bissulfonamide derivatives as enzyme inhibitors |
| 06/14/2001 | WO2001000812A3 22012, a novel human carboxypeptidase |
| 06/14/2001 | US20010003646 Composition for keeping away vermin |
| 06/14/2001 | US20010003589 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
| 06/14/2001 | CA2394303A1 Interferon-alpha induced gene |
| 06/14/2001 | CA2392961A1 G-protein coupled receptors |
| 06/14/2001 | CA2392584A1 Substituted pyridazines having cytokine inhibitory activity |